Reader Comments

Post a new comment on this article

On the "endothelial" origin of ECV304 cells

Posted by FVanValen on 18 May 2015 at 07:56 GMT

Dear PLoS One Staff, Dear Authors

While gathering information about cell line ECV304 in the literature, I noticed that a number of papers on cell line ECV304 have been published in PLoS One [1-9], with 5 recent publications in the year 2014 [1-5]. In the majority of these papers [1-8], the authors have referred to ECV304 as an endothelial cell line, and thus their experiments have been carried out using ECV304 as a reliable endothelial model system. However, in one paper published in PloS One, the authors referred to ECV304 as a bladder carcinoma cell line [9].
Where does the confusion come from?
ECV304 has been originally established as an immortalized endothelial cell line by Takahashi in 1990 [10]. However, in 1999 the German Collection of Microorganisms and Cell Cultures (DSMZ) has reported the cross-contamination [11] between the human cell lines ECV304 [10] and T24 [12], a bladder carcinoma cell line. Subsequently, in 1999 the Japanese Collection of Research Bioresources (JCRB) Cell Bank investigated this cross-contamination using cytogenetic analysis and the short tandem repeat (STR) profiles of ECV304 and T24 and verified the cross-contamination [13]. Ever since, the cross-contamination has been successfully confirmed in additional laboratories [14, 15]. Collectively, the “endothelial-like” ECV304 is now widely recognized as a derivative of the T24 bladder carcinoma cell line.

References

1. Cugno M, Marzano AV, Lorini M, Carbonelli V, Tedeschi A (2014) Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. PLoS One 9:e111862
2. Kowshik J, Baba AB, Giri H, Deepak Reddy G, Dixit M, Nagini S (2014) Astaxanthin inhibits JAK/STAT-3 signaling to abrogate cell proliferation, invasion and angiogenesis in a hamster model of oral cancer. PLoS One 9:e109114
3. Veronez CL, Nascimento FD, Melo KR, Nader HB, Tersariol IL, Motta G (2014) The involvement of proteoglycans in the human plasma prekallikrein interaction with the cell surface. PLoS One 9:e91280
4. Cai X, Chen Z, Pan X, Xia L, Chen P, Yang Y, Hu H, Zhang J, Li K, Ge J, Yu K, Zhuang J (2014) Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis. PLoS One 9:e88176
5. Novakova I, Subileau EA, Toegel S, Gruber D, Lachmann B, Urban E, Chesne C, Noe CR, Neuhaus W (2014) Transport rankings of non-steroidal antiinflammatory drugs across blood-brain barrier in vitro models. PLoS One 9:e86806
6. Shwetank, Date OS, Kim KS, Manjunath R (2013) Infection of human endothelial cells by Japanese encephalitis virus: increased expression and release of soluble HLA-E. PLoS One 8:e79197
7. Wurster T, Pölzelbauer C, Schönberger T, Paul A, Seizer P, Stellos K, Schuster A, Botnar RM, Gawaz M, Bigalke B (2012) Green fluorescent protein (GFP) color reporter gene visualizes parvovirus B19 non-structural segment 1 (NS1) transfected endothelial modification. PLoS One 7:e33602
8. Manente AG, Pinton G, Tavian D, Lopez-Rodas G, Brunelli E, Moro L (2011) Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability. PLoS One 6:e25676
9. Ren X, Xu J, Cooper JP, Kang MH, Erdreich-Epstein A (2012) c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. PLoS One 7:e42291
10. Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T (1990) Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev Biol 3:265-274
11. Dirks WG, MacLeod RA, Drexler HG (1999) ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross- contamination at source. In Vitro Cell Dev Biol Anim 35:558-559
12. Bubenik J, Baresova M, Viklicky V, Jakoubkova J, Sainerova H, Donner J (1973) Established cell line of urinary bladder carcinoma (T24) containing tumour specific antigen. Int J Cancer 11:765-773
13. Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, Mizsawa H (1999) Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24. Tiss Cult Res Commun 18:329-338
14. Suda K, Rothen-Rutishauser B, Günthert M, Wunderli-Allenspach HP (2001) Phenotypic characterization of human umbilical vein endothelial (ECV304) and urinary carcinoma (T24) cells: endothelial versus epithelial features. In Vitro Cell Dev Biol Anim 37:505-514
15. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, Longland CL, Michelangeli F, Dubrova YE, Brown CA (2000) Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab Invest 80:37-45

No competing interests declared.

RE: On the "endothelial" origin of ECV304 cells

guacydamotta replied to FVanValen on 03 Jun 2015 at 20:35 GMT

Dear Dr. van Valen,

We appreciate your comment and we understand your concern. In our lab we are aware and have the same concern about ECV304 cells. We got our ECV304 cells from the American Type Culture Collection (ATCC) and we have some unpublished data regarding to characterization and comparison of two different endothelial cell lines ECV304 (Takahashi K, Sawasaki Y, Hata J, Mukai K, Goto T, 1990) and the other derived from rabbit aorta (Buonassisi V and Venter JC, 1976. Proc. Nat. Acad. Sci. USA, 73:1612-16). In ECV304 cells we determined the expression of von Willebrand Factor by confocal microscopy and flow citometry using a goat IgG anti-von Willebrand Factor (Santa Cruz, Inc.) and the cells were positive as expected (McComb, R.D. et al., 1982). We also analyzed the presence of Syndecan4 using a monoclonal antibody anti-SYN4, produced in our lab and raised against a synthetic peptide containing the first 29N-terminal aminoacids of syndecan-4, and the cells were positive as expected (Castillo et al., 1987; Ferrari do Outeiro-Bernstein et al., 2002). We concluded that the ECV304 cell line we work on are endothelial cells.

McComb, R.D. et al., 1982. J Histochem Cytochem 30:371-377.
Castillo, C.J. et al., 1987. Biochem J 247:687-93.
Ferrari do Outeiro-Bernstein, M.A. et al., 2002. Matrix Biol 21:311-324.

No competing interests declared.